SEARCH

SEARCH BY CITATION

References

  • 1
    Bosch J, Pizcueta P, Feu F, Fernández M, García-Pagán JC. Pathophysiology of portal hypertension. Gastroenterol Clin North Am 1992; 21: 114.
  • 2
    Stark ME, Szurszewski JH. Role of nitric oxide in gastrointestinal and hepatic function and disease. Gastroenterology 1992; 103: 19281949.
  • 3
    Vallance P, Moncada S. Hyperdynamic circulation in cirrhosis: a role for nitric oxide? Lancet 1991; 337: 776778.
  • 4
    Sieber CC, Groszmann RJ. In vitro hyporeactivity to methox-amine in portal hypertensive rats: reversal by nitric oxide blockade. Am J Physiol 1992; 262: G996G1001.
  • 5
    Sieber CC, Groszmann RJ. Nitric oxide mediates hyporeactivity to vasopressors in mesenteric vessels of portal hypertensive rats. Gastroenterology 1992; 103: 235239.
  • 6
    Lee F-Y, Albillos A, Colombato LA, Groszmann RJ. The role of nitric oxide in the vascular hyporesponsiveness to methoxamine in portal hypertensive rats. Hepatology 1992; 16: 10431048.
  • 7
    Pizcueta P, Piqué JM, Fernández M, Bosch J, Rodés J, Whittle BJR, Moncada S. Modulation of the hyperdynamic circulation of cirrhotic rats by nitric oxide inhibition. Gastroenterology 1992; 103: 19091915.
  • 8
    Pizcueta MP, Piqué JM, Bosch J, Whittle BJR, Moncada S. Effects of inhibiting nitric oxide biosynthesis on the systemic and splanchnic circulation of rats with portal hypertension. Br J Pharmacol 1992; 105: 184190.
  • 9
    Clària J, Jiménez W, Ros J, Asbert M, Castro A, Arroyo V, Rivera F, et al. Pathogenesis of arterial hypotension in cirrhotic rats with ascites: role of endogenous nitric oxide. Hepatology 1992; 15: 343349.
  • 10
    Sieber CC, Lopez-Talavera JC, Groszmann RJ. Role of nitric oxide in the in vitro splanchnic hyporeactivity in ascitic cirrhotic rats. Gastroenterology 1993; 104: 17501754.
  • 11
    Castro A, Jiménez W, Clària J, Ros J, Martínez JP, Bosch M, Arroyo V, et al. Impaired responsiveness to angiotensin II in experimental cirrhosis: role of nitric oxide. Hepatology 1993; 18: 367372.
  • 12
    Guarner C, Soriano G, Tomas A, Bulbena O, Novella MT, Ba-lanzo J, Vilardell F, et al. Increased serum nitrite and nitrate levels in patients with cirrhosis: relationship to endotoxemia. Hepatology 1993; 18: 11391143.
  • 13
    Hori N, Takahashi H, Okanoue T, Mori T, Sakamoto S, Nanbu A, Yoshimura M, et al. Nitric oxide production in patients with chronic liver diseases. Hepatology 1993; 18: 101A.
  • 14
    Le Moine O, Soupison T, Sogni P, Husson C, Cruziaux A, Marchant A, Moreau R, et al. The role of endotoxins and TNFα in the hyperkinetic circulation of cirrhosis. J Hepatol 1993; 18(suppl 1): S40.
  • 15
    Sogni P, Moreau R, Ohsuga M, Cailmail S, Oberti F, Hadengue A, Pussard E, et al. Evidence for normal nitric oxide-mediated vasodilator tone in conscious rats with cirrhosis. Hepatology 1992; 16: 980983.
  • 16
    Cahill PA, Wu YP, Sitzmann JV. Nitric oxide synthase activity in portal hypertension. Hepatology 1993; 18: 141A.
  • 17
    Michielsen PP, Boeckxstaens GE, Pelckmans PA, Herman AG, Van Maercke YM. Role of nitric oxide in vascular reactivity of isolated conductance vessels in portal hypertensive rats. Gastroenterology 1993; 104: A954.
  • 18
    Fernández M, García-Pagán JC, Casadevall M, Bernadich C, Piera C, Whittle BJR, Piqué JM, et al. Evidence against a role for inducible nitric oxide synthase in the hyperdynamic circulation of portal hypertensive rats. Gastroenterology 1995; 108: 14871495.
  • 19
    García-Pagán JC, Casadevall M, Fernández M, Bernadich C, Whittle BJM, Piqué JM, Bosch J, et al. Chronic dexamethasone administration does not modify the hyperdynamic circulation in portal hypertensive rats. Gastroenterology 1994; 106: A897.
  • 20
    Clària J, Jiménez W, Ros J, Rigol M, Angeli P, Arroyo V, Rivera F, et al. Increased nitric oxide-dependent vasorelaxation in aortic rings of cirrhotic rats with ascites. Hepatology 1994; 20: 16151621.
  • 21
    Proctor E, Chatamra K. High yield micronodular cirrhosis in the rat. Gastroenterology 1982; 83: 11831190.
  • 22
    Firth JD, Gove C, Panos MZ, Raine AEG, Williams R, Leding-ham JGG. Sodium handling in the isolated perfused kidney of the cirrhotic rat. Clin Sci 1989; 77: 657661.
  • 23
    Ralevic V, Burnstock G. Actions mediated by P2-purinoceptor subtypes in the isolated mesenteric bed of the rat. Br J Pharmacol 1988; 95: 637645.
  • 24
    Altman DG. Practical statistics for medical research. London: Chapman & Hall, 1991: 210212.
  • 25
    Whittle BJR, Moncada S. Nitric oxide: the elusive mediator of the hyperdynamic circulation of cirrhosis? Hepatology 1992; 16: 10891092.
  • 26
    Hartleb M, Moreau R, Lebrec D. The limited opening of L-type calcium channels contributes more to the vascular hyporeactivity to endothelin-1 in rats with cirrhosis than the overproduction of nitric oxide. Hepatology 1993; 18: 99A.
  • 27
    Moreau R, Komeichi H, Kirstetter P, Ohsuga M, Cailmail S, Lebrec D. Altered control of vascular tone by adenosine triphosphate-sensitive potassium channels in rats with cirrhosis. Gas-troenterology 1994; 106: 10161023.
  • 28
    Lüscher TF, Richard V, Yang Z. Interaction between endothe-lium-derived nitric oxide and SIN-1 in human and porcine blood vessels. J Cardiovasc Pharmacol 1989; 14(suppl 11): S76S80.
  • 29
    Moncada S, Rees DD, Schulz R, Palmer RMJ. Development and mechanisms of a specific supersensitivity to nitrovasodilators after inhibition of vascular nitric oxide synthesis in-vivo. Proc Natl Acad Sci U S A 1991; 88: 21662170.
  • 30
    Ralevic V, Mathie RT, Alexander B, Burnstock G. NG-Nitro-l-arginine methyl ester attenuates vasodilator responses to acetyl-choline but enhances those to sodium nitroprusside. J Pharm Pharmacol 1991; 43: 871874.
  • 31
    Tsuchida S, Hitaoka M, Sudo M, Kigoshi S, Muramatsu I. Attenuation of sodium nitroprusside responses after prolonged incubation of rat aorta with endotoxin. Am J Physiol 1994; 267: H2305H2310.
  • 32
    MacGilchrist AJ, Sumner D, Reid JL. Impaired pressor reactivity in cirrhosis: evidence for a peripheral vascular defect. Hepatology 1991; 13: 689694.
  • 33
    Adeagbo ASO, Triggle CR. Varying extracellular [K+]: a functional approach to separating EDHF- and EDNO-related mechanisms in perfused rat mesenteric arterial bed. J Cardiovasc Pharmacol 1993; 21: 423429.
  • 34
    Randall MD, Hiley CR. Effect of phenobarbitone pretreatment upon endothelium-dependent relaxation to acetylcholine in rat superior mesenteric arterial bed. Br J Pharmacol 1988; 94: 977983.
  • 35
    Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288: 373376.